Emissions from shipping could grow by 250% by 2050 if no action is taken.
Halving shipping’s emissions by 2050 could require $1.4 trillion in investment.
But the scale of this challenge could be big
enough to spur decarbonization across other sectors, too.
The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.
European Federation of Pharmaceutical Industries and Associations